Literature DB >> 7201577

Maximizing the harvest of contrast enhancing lesions in multiple sclerosis.

E S Sears, A McCammon, R Bigelow, L A Hayman.   

Abstract

Transient contrast enhancing lesions can be seen with CT in patients with MS, particularly during acute exacerbations. Conventional 40 gm iodine enhancement technique followed by immediate postinfusion scanning was compared with high dose (80 gm iodine) enhancement technique followed by a 1-hour delayed CT scan; delayed high dose technique (DHD) in nine exacerbations. New lesions, totaling 36 in all, were observed in each case with the DHD technique. With time, the borders expanded in 98% of lesions, thus confirming in vivo that a defective blood-brain barrier (BBB) underlies this phenomenon.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7201577     DOI: 10.1212/wnl.32.8.815

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  The diagnostic challenge of multiple sclerosis.

Authors:  T P Seland
Journal:  Can Fam Physician       Date:  1984-07       Impact factor: 3.275

2.  High-dose contrast-enhanced MRI in multiple sclerosis.

Authors:  T Koudriavtseva; C Pozzilli; C Di Biasi; M Iannilli; G Trasimeni; C Gasperini; C Argentino; G F Gualdi
Journal:  Neuroradiology       Date:  1996-05       Impact factor: 2.804

3.  Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis.

Authors:  M Filippi; R Capra; A Campi; B Colombo; F Prandini; N Marcianò; R Gasparotti; G Comi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

4.  Evaluation by MRI of paraparesis and tetraparesis of undiagnosed aetiology.

Authors:  E B Ringelstein; D Krieger; B Hünermann
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

5.  Multiple sclerosis: diagnostic value of computerized tomography with delayed scanning after a double-dose of contrast medium in comparison with other diagnostic tests.

Authors:  C Weitze; G Hertel; W Brittner
Journal:  Neurosurg Rev       Date:  1988       Impact factor: 3.042

6.  Correlation between multimodal evoked potentials and magnetic resonance imaging in multiple sclerosis.

Authors:  G Comi; V Martinelli; S Medaglini; T Locatelli; M Filippi; N Canal; F Triulzi; A Del Maschio
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

7.  Protein pattern of cerebrospinal fluid in various neurological diseases.

Authors:  C R Hornig; O Busse; W Dorndorf
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1983

8.  Verapamil-induced changes in central conduction in patients with multiple sclerosis.

Authors:  R L Gilmore; E J Kasarskis; R G McAllister
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-11       Impact factor: 10.154

9.  CT scan changes in multiple sclerosis among Malaysian patients.

Authors:  C T Tan; D Abdullah; A H Zakariya
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

10.  Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis.

Authors:  M Filippi; A Campi; V Martinelli; B Colombo; T Yousry; N Canal; G Scotti; G Comi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.